CONCORD DRUGS
|
The Current P/S Ratio of CONCORD DRUGS is 1.15.
| Share Price | ₹74.9 | Aug 11,2026 |
| Market Cap | ₹98.9 Cr | |
| Sales-TTM | ₹86.1 Cr | TTM-Consolidated Results |
| Price/Sales | 1.15x | Calculated as Market Cap/Sales |
|---|---|---|
| Explore Stock Analytics | ||
Definition & Calculation of PS (Price/Sales) ratio of CONCORD DRUGS
P/S =
Market Capitalization
/
Sales
or, using per-share numbers:
P/S = Stock Price / Sales Per Share
Current Market Cap [ ₹98.9 Cr] as on Aug 11,2026
(/) Sales [ ₹86.1 Cr] based on TTM-Consolidated Results
(=) P/S Ratio [ 1.15x ]
Thus, for CONCORD DRUGS , the investors are currently willing to pay '1.15 times sales' to own 1 share of the company.
PS Multiples are one of the most widely used valuation multiple in the industry.
P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.
You may also explore Price to Earnings ratio or Price to Book ratio of CONCORD DRUGS !
The chart below summarizes the trend in P/S Ratio of CONCORD DRUGS over the last five years.
Historical PS (Price/Sales) ratio chart of CONCORD DRUGS
PS Ratio Performance Analysis for CONCORD DRUGS
- CONCORD DRUGS 's p/e ratio for fiscal years ending Mar2025 to Mar2022 averaged 0.60x.
- CONCORD DRUGS 's operated at median p/e ratio of 0.69x from fiscal years ending March 2018 to 2022.
- Looking back at the last 4 fiscal years, CONCORD DRUGS 's p/e ratio peaked in Mar2024 at 0.78x.
- CONCORD DRUGS 's p/e ratio hit its five-year low in Mar2022 of 0.43x.
How does CONCORD DRUGS 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
| Peer Comparison (Pharmaceuticals & Drugs Industry) | Sales (Cr) | PS Ratio | Market Cap (Cr) |
|---|---|---|---|
| CONCORD DRUGS | 86.1 | 1.15 | 98.9 |
| SUN PHARMACEUTICAL INDUSTRIES LTD | 59,910.5 | 7.77 | 465,471.0 |
| DIVIS LABORATORIES LTD | 11,230.0 | 20.18 | 226,631.0 |
| TORRENT PHARMACEUTICALS LTD | 15,723.0 | 11.78 | 185,157.0 |
| CIPLA LTD | 28,324.4 | 4.17 | 118,108.0 |
| DR REDDYS LABORATORIES LTD | 33,227.9 | 3.03 | 100,578.0 |
| MANKIND PHARMA LTD | 14,737.9 | 6.80 | 100,152.0 |
| LUPIN LTD | 29,966.6 | 3.48 | 104,158.0 |
| ZYDUS LIFESCIENCES LTD | 28,591.7 | 4.12 | 117,705.0 |
| AUROBINDO PHARMA LTD | 34,935.3 | 2.70 | 94,477.0 |
| LAURUS LABS LTD | 7,269.6 | 13.82 | 100,498.0 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs CONCORD DRUGS 's P/S Ratio
| Top 10 Industry Peers | PS Ratio |
|---|---|
| Min industry PS | 1.15x |
| Max industry PS | 20.18x |
| Median industry PS | 4.17x |
| Average industry PS | 7.18x |
You may also like the below Video Courses